Bristol-Myers Squibb Company (NYSE:BMY) — Stock Price

$64.84 USD
▲ 0.19% today

Bristol-Myers Squibb Company (NYSE:BMY) is currently trading at $64.84 USD, up 0.19% today. Over the past 52 weeks, shares have ranged between $42.60 and $65.89. This page tracks Bristol-Myers Squibb Company's live share price on the NYSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Bristol-Myers Squibb Company (BMY) market capitalisation.

Bristol-Myers Squibb Company (BMY) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Bristol-Myers Squibb Company's daily closing share price and trading volume on the NYSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Bristol-Myers Squibb Company Income Statement — Revenue, Profit & Earnings by Year

Bristol-Myers Squibb Company's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue $48.19 Billion $48.30 Billion $45.01 Billion $46.16 Billion $46.38 Billion
Cost of Revenue $15.59 Billion $20.87 Billion $19.65 Billion $19.67 Billion $19.62 Billion
Gross Profit $32.60 Billion $27.43 Billion $25.36 Billion $26.49 Billion $26.76 Billion
Research & Development $9.61 Billion $9.78 Billion $9.21 Billion $9.41 Billion $9.53 Billion
SG&A $5.66 Billion $6.37 Billion $6.28 Billion $7.81 Billion $7.69 Billion
Total Operating Expenses $19.91 Billion $17.77 Billion $16.89 Billion $17.22 Billion $17.22 Billion
Operating Income $12.70 Billion $9.66 Billion $8.47 Billion $9.27 Billion $9.54 Billion
EBITDA $14.54 Billion $3.17 Billion $19.37 Billion $19.22 Billion $20.12 Billion
EBIT $10.69 Billion $-6.43 Billion $9.61 Billion $8.95 Billion $9.43 Billion
Interest Expense $1.51 Billion $1.95 Billion $1.17 Billion $1.23 Billion $1.33 Billion
Income Before Tax $9.33 Billion $-8.38 Billion $8.44 Billion $7.71 Billion $8.10 Billion
Income Tax Expense $2.27 Billion $554.00 Million $400.00 Million $1.37 Billion $1.08 Billion
Net Income $7.05 Billion $-8.95 Billion $8.03 Billion $6.33 Billion $6.99 Billion

Bristol-Myers Squibb Company Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Bristol-Myers Squibb Company's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets $90.04 Billion $92.60 Billion $95.16 Billion $96.82 Billion $109.31 Billion
Total Current Assets $29.39 Billion $29.78 Billion $31.77 Billion $27.27 Billion $33.26 Billion
Cash & Equivalents $10.21 Billion $10.35 Billion $11.46 Billion $9.12 Billion $13.98 Billion
Short-term Investments $464.00 Million $513.00 Million $816.00 Million $130.00 Million $3.24 Billion
Net Receivables $14.53 Billion $14.42 Billion $15.26 Billion $13.94 Billion $12.52 Billion
Inventory $2.69 Billion $2.56 Billion $2.66 Billion $2.34 Billion $2.10 Billion
Property, Plant & Equipment $9.12 Billion $8.36 Billion $8.04 Billion $6.25 Billion $6.05 Billion
Goodwill $21.75 Billion $21.72 Billion $21.17 Billion $21.15 Billion $20.50 Billion
Total Liabilities $71.53 Billion $76.22 Billion $65.67 Billion $65.70 Billion $73.31 Billion
Total Current Liabilities $23.42 Billion $23.77 Billion $22.26 Billion $21.89 Billion $21.87 Billion
Long-term Debt $42.85 Billion $47.60 Billion $36.65 Billion $35.06 Billion $39.60 Billion
Net Debt $36.93 Billion $40.85 Billion $30.00 Billion $31.59 Billion $31.62 Billion
Total Stockholder Equity $18.47 Billion $16.34 Billion $29.43 Billion $31.06 Billion $35.95 Billion
Retained Earnings $16.90 Billion $14.91 Billion $28.77 Billion $25.50 Billion $23.82 Billion

Bristol-Myers Squibb Company Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Bristol-Myers Squibb Company generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow $14.16 Billion $15.19 Billion $13.86 Billion $13.07 Billion $16.21 Billion
Capital Expenditures $1.31 Billion $1.25 Billion $1.21 Billion $1.12 Billion $973.00 Million
Free Cash Flow $12.85 Billion $13.94 Billion $12.65 Billion $11.95 Billion $15.23 Billion
Investing Cash Flow $-4.13 Billion $-21.35 Billion $-2.29 Billion $-1.06 Billion $-538.00 Million
Financing Cash Flow $-10.35 Billion $5.13 Billion $-9.42 Billion $-16.96 Billion $-16.22 Billion
Dividends Paid $-5.04 Billion $-4.86 Billion $-4.74 Billion $4.63 Billion $4.40 Billion
Stock-Based Compensation $553.00 Million $507.00 Million $518.00 Million $457.00 Million $583.00 Million
Depreciation $4.01 Billion $9.60 Billion $9.76 Billion $10.28 Billion $10.69 Billion
Change in Cash $-137.00 Million $-1.17 Billion $2.19 Billion $-4.99 Billion $-657.00 Million

Bristol-Myers Squibb Company Earnings History — EPS Actual vs. Analyst Estimates

Track Bristol-Myers Squibb Company's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 30, 2026 1.58 1.44 +9.72%
Feb 05, 2026 1.26 1.63 -22.70%
Oct 30, 2025 1.63 1.69 -3.55%
Jul 31, 2025 1.46 1.10 +32.73%
Apr 24, 2025 1.80 1.50 +20.00%
Feb 06, 2025 1.67 1.47 +13.61%
Oct 31, 2024 1.80 1.50 +20.00%
Jul 26, 2024 2.07 1.63 +26.99%